ELEKTA VMAT 510(k) CLEARANCE WELCOMED BY US RADIATION ONCOLOGISTS
Press ReleaseStockholm, Sweden, June 16, 2008Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes.From the patient's perspective, Elekta VMAT (Volumentric intensty Modulated Arc Therapy) combines a significant reduction in treatment